38FULE Lady Care Plaster
Natural health product licensed in Canada
- Licence holder
- 38FULE Corporation
- NPN or DIN-HM
- 80090016
- Status
- Inactive licence
- Licence date
- 9 January 2019
- Revision date
- Not provided
- Form
- Plâtre
- Route of administration
- Topique
- Application type
- Officinale
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Foeniculum vulgare Source : Fruit Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 300 milligramme | 60 milligramme |
| Cinnamomum aromaticum Source : Stem bark - inner Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 100 milligramme | 20 milligramme |
| Syzygium aromaticum Source : Bourgeon floral Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 50 milligramme | 10 milligramme |
| Dryobalanops aromatica Source : Ramification feuillée | 10 milligramme |
| Phellodendron chinense Source : Écorce (tige) Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 200 milligramme | 40 milligramme |
| Cyperus rotundus Source : Rhizome Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 50 milligramme | 10 milligramme |
| Tetradium ruticarpum Source : Fruit Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 500 milligramme | 100 milligramme |
| Angelica sinensis Source : Racine Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 100 milligramme | 20 milligramme |
| Sophora flavescens Source : Racine Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 300 milligramme | 60 milligramme |
Non-medicinal ingredients
(p)-hydroxybenzoate d'éthyle, Miel
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 pansement adhésif | 1 day |
Uses authorised in Canada
Combination of Traditional Chinese Medicine Ingredients.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
If you experience breast pain, discomfort and/or tenderness, discontinue use and consult a health care practitioner. Hypersensitivity/allergy may occur; in which case, discontinue use.
- Contre-indications
If you are pregnant or breastfeeding, do not use this product. If allergies such as rash or irritation occur, discontinue immediately. If you have allergy/hypersensitivity to members of the Apiaceae/Umbelliferae family (anise, caraway, carrot, celery, dill, parsley), do not use this product. If you have diarrhoea or haemorrhagic diseases, do not use this product. If you have hypermenorrhoea, do not use this product.
- Précautions et mises en garde
If symptoms persist or worsen, or if new symptoms develop, discontinue use and consult a health care practitioner. If you are taking prescription medications, eg. birth control pills, hormone replacement therapy (HRT), blood thinners/ anticoagulants, consult a health care practitioner prior to use. If menstruation is delayed or absent, or if you experience increased menstrual bleeding time, discontinue use and consult a health care practitioner. If you have family history of cancer, diabetes, consult a healthcare practitioner prior to use. If breastfeeding, consult a health care practitioner prior to use.
Source
Official Health Canada record, licence 80090016
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.